C
Culmination
Biotech & Life Sciences · St. George, United States · Founded 2022
Revolutionizing healthcare with cutting-edge insights and discoveries MoreLess
Culmination Bio Inc., headquartered in St. George, Utah, is a pioneering company in the healthcare sector, focusing on the discovery and implementation of advanced clinical insights and therapeutic innovations. The company operates at the intersection of healthcare and technology, partnering with leading technology firms and biopharmaceutical companies to drive forward the future of personalized medicine.
Culmination Bio serves a diverse range of clients, including healthcare providers, researchers, and commercial partners. Their primary market is the healthcare industry, with a strong emphasis on precision medicine, which tailors medical treatment to the individual characteristics of each patient. This approach is made possible through the use of multimodal data, which combines information from various sources to create a comprehensive picture of patient health.
The business model of Culmination Bio is built around collaboration and innovation. By partnering with top-tier technology and biopharmaceutical companies, they are able to leverage their multidisciplinary team's expertise to discover new therapeutic targets, diagnostic opportunities, and care process models. This collaborative approach not only accelerates the pace of discovery but also ensures that the insights generated are both practical and applicable in real-world settings.
Culmination Bio generates revenue through these strategic partnerships and the commercialization of their discoveries. They provide high-value data and insights that are tailored for innovation, which their partners can then use to develop new treatments, diagnostics, and healthcare solutions. This model ensures a steady stream of income while also contributing to the advancement of healthcare.
In summary, Culmination Bio is a forward-thinking company dedicated to improving healthcare through innovative discoveries and strategic partnerships. Their work is transforming the way we understand and treat diseases, making personalized care a reality for more people.
Keywords: healthcare innovation, personalized medicine, clinical insights, therapeutic targets, diagnostic opportunities, multimodal data, strategic partnerships, precision medicine, biopharmaceutical, technology collaboration.
Valuation & funding
Culmination funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Nov 2023 | $10M | $40M | Merck Global Health Innovation Fund · Amgen Ventures | ↗ |
| SPINOUTOther financing | Jan 2022 | $0 | — | Intermountain Healthcare | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 29 |
| 2025 | 29 |
| 2024 | 30 |
| 2023 | 18 |
Growth signals
Culmination website traffic
Latest recorded traffic for Culmination is 1.6K monthly website visits, down 11.1% over the last three months. Culmination's team grew 0% over the past year.
Comparisons
Culmination compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Culmination's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on Culmination's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Culmination has talent and traffic
In the news
Latest news about Culmination
Recent press, funding announcements, and product moves mentioning Culmination — open to read from the original sources.
Market sentiment
What the market is saying about Culmination
An AI-synthesized read of the highest-engagement posts about Culmination on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Culmination’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.